NCT00334646View on ClinicalTrials.gov

Cyclophosphamide Drug Interaction Study In Cancer Patients

PHASE1TerminatedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 10, 2005

Primary Completion Date

October 14, 2009

Study Completion Date

October 14, 2009

Conditions
Nausea and Vomiting, Chemotherapy-Induced
Interventions
DRUG

Oral GW679769

150mg oral, once daily on days 1-3

DRUG

IV Cyclophosphamide 500-700mg/m2

IV Cyclophosphamide 500-700mg/m2 on day 1 of each cycle

Trial Locations (5)

8011

GSK Investigational Site, Christchurch

10461

GSK Investigational Site, The Bronx

19713

GSK Investigational Site, Newark

87131

GSK Investigational Site, Albuquerque

SE-221 85

GSK Investigational Site, Lund

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY